Search

Green hearing services: sustainable care for people and the planet

Environmental resource depletion is no longer a distant threat; it is a current health emergency. Sustainable hearing services are kind to both people and the planet. In January 2026, the International Society of Audiology hosted a webinar bringing together those...

Endoscopic airway interventions in children

Open surgery for paediatric airway pathologies such as subglottic stenosis was hailed as revolutionary when many of today’s paediatric ORL specialists were in training. Equipment, facilities and training has moved on and the high-quality optics in modern endoscopes, coupled with...

ENT in the Balkans

Shining a light on ENT in the Balkans, Metin Önerci explains the population and challenges in this part of the world. There is no universal agreement on what constitutes the Balkans. However, the following countries are usually included: Albania, Bosnia...

Hearing loss in the workplace

It is probably accurate to say that most jobs today can be effectively performed by people who have hearing loss. In this article Dr Sam Trychin outlines some of the major issues which should be considered in regard to hearing...

The effects of polypharmacy in the elderly

Another pill to cure the ill? Alec Lapira discusses the warning signs of polypharmacy in the elderly population. Polypharmacy in the elderly Polypharmacy – defined as the use of five or more medications – occurs in 20–37% of older people...

In conversation with Sam Lear, BAA President: leading audiology forward

Dr Samantha Lear is the current British Academy of Audiology President, and Senior Audiology Policy Advisor at the National Deaf Children’s Society. With reviews ongoing in paediatric audiology in England and Scotland, Sam is ideally placed to lead the profession....

The changing spectrum of cancer of the oropharynx: dilemmas and future directions

The association of HPV in oropharyngeal cancer has identified a ‘new disease’, with its unique biologic behaviour, and challenges for clinicians in selecting therapeutic combinations offering maximum efficacy and minimum morbidity or long-term sequela currently under study in clinical trials....